The American Institute of Cancer Research recommends a diet filled with a variety of fruits, vegetables, grains and ...

A team from the Montreal Clinical Research Institute has identified a protein that could play a role in the spread of breast ...

Prior studies have found strong links between marijuana use and later cardiovascular disease. A February 2024 study found ...

Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

Patritumab deruxtecan was unable to significantly improve overall survival in patients with locally advanced or metastatic ...

The combination of two cancer drugs, rapamycin and trametinib, can extend the lifespan of mice by 30%, according to a study ...

Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent Post-TB Lung Disease, Study Suggests Apr. 21, 2025 — An experimental drug now in clinical trials as a cancer ...

There are two main types of lung cancer ... approach that tailors cancer care and lifestyle recommendations to each patients’ biopsychosocial-spiritual circumstances. He partners with patients ...

A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd).

AbbVie has claimed its first global regulatory approval, from the FDA, for its C-met-targeting lung cancer ADC Emrelis.

Background Insomnia symptoms are prevalent in older adults and linked to cardiovascular disease (CVD), but the role of ...